Welcome to Fermion! We are one of the leading companies active in API’s for the innovative and generic drugs industry. Founded in 1969 as a company developing products through fermentation and being a daughter company of Orion Corporation, we offer Contract Research and Manufacturing Services to third parties read moreworldwide. Ten innovative products, for which Fermion developed the API, have either been filed or launched/commercialized worldwide.

We offer partnering for in-licensing and co-marketing, contract manufacturing for dosage forms, contract manufacturing for small-scale APIs and being competitive in the API space by co-operating with partners for procuring early intermediates. We have two FDA-inspected plants and manufacture more than 220 tons of API per year. [website]

Since 1950, FLAMMA continues to be one of the preeminent manufacturers of high value chiral APIs and intermediates for the pharmaceutical industry. Are you making small peptides or molecules containing natural and/or unnatural amino acids? If so, FLAMMA makes sense as a CMO. Numerous top 20 pharma/biotechs understand read morethe value that FLAMMA brings and work with our team as one of their preferred suppliers.

FLAMMA has 3 manufacturing facilities all with R&D & kilo labs for small scale needs. Both Italian locations (Chignolo & Isso) are cGMP facilities that are regularly inspected by the FDA, AIFA, & customers. FLAMMA's Dalian, China facilities feature a non-cGMP production plant.

FLAMMA is fully integrated and leverages their self-owned, self-managed facilities in China to deliver results. FLAMMA reliably supplies materials directly customers and/or they deliver materials (when required) to their cGMP facilities in Italy in order to deliver the customer's compound on-time with the required specifications. FLAMMA offers cost-effective services to customers looking for a trusted partner within China.

With a total capacity of 360 m³ & over 300 employees, find out why FLAMMA should be a CMO you consider for your next project.